In further details, in CRC, BPA, although structurally and functionally similar to E2, acts directly via steroid hormone receptors, interacting with ERβ with a lower affinity than E2 and behaving as an E2 antagonist by blocking ERβ activities [47,48]. Here, ESR2 is linked to colorectal carcinoma.